Qualigen Therapeutics, Inc. (QLGN)

NASDAQ: QLGN · IEX Real-Time Price · USD

0.293

-0.022 (-6.90%)

At close: Jul 19, 2024, 4:00 PM

0.279

-0.014 (-4.88%)

Pre-market: Jul 22, 2024, 7:40 AM EDT

Qualigen Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Mar 31, 2020	Dec 31, 2019	2018 - 2013
Revenue	1.63	0	0	5.65	5.56	0	Upgrade
Revenue Growth (YoY)	13.74%	-	-	1.72%	-	-	Upgrade
Cost of Revenue	1.02	0	0	4.33	3.98	0	Upgrade
Gross Profit	0.61	0	0	1.32	1.58	0	Upgrade
Selling, General & Admin	6.19	6.1	10.27	12.27	1.88	4.57	Upgrade
Research & Development	4.44	5.21	4.49	11.72	1.21	6.13	Upgrade
Other Operating Expenses	0	0	0	0	0	0.15	Upgrade
Operating Expenses	10.64	11.3	14.76	23.98	3.08	10.84	Upgrade
Operating Income	-10.03	-11.3	-14.76	-22.66	-1.5	-10.84	Upgrade
Interest Expense / Income	1.12	1.52	0.03	-0.04	0.28	0	Upgrade
Other Expense / Income	0.5	0.59	3.84	-4.73	-0	-0.71	Upgrade
Pretax Income	-11.64	-13.42	-18.63	-17.89	-1.78	-10.13	Upgrade
Income Tax	-0.04	-0	0.01	0.01	0	0	Upgrade
Net Income	-11.6	-13.42	-18.64	-17.9	-1.79	-10.13	Upgrade
Preferred Dividends	0.06	0	0	0	0	0	Upgrade
Shares Outstanding (Basic)	6	5	4	3	1	0	Upgrade
Shares Outstanding (Diluted)	6	5	4	3	1	0	Upgrade
Shares Change	19.86%	32.09%	30.91%	423.63%	1363.48%	80.40%	Upgrade
EPS (Basic)	-2.23	-2.65	-4.86	-6.10	-3.20	-265.00	Upgrade
EPS (Diluted)	-2.23	-2.65	-4.86	-6.10	-3.20	-265.00	Upgrade
Free Cash Flow	-8.26	-10.3	-13.25	-14.87	0.05	-14.52	Upgrade
Free Cash Flow Per Share	-1.39	-2.03	-3.45	-5.07	0.09	-379.26	Upgrade
Gross Margin	37.52%	-	-	23.37%	28.43%	-	Upgrade
Operating Margin	-616.17%	-	-	-400.85%	-27.05%	-	Upgrade
Profit Margin	-716.87%	-	-	-316.55%	-32.16%	-	Upgrade
Free Cash Flow Margin	-507.41%	-	-	-262.93%	0.91%	-	Upgrade
EBITDA	-10.64	-11.89	-18.59	-17.6	-1.28	-10.02	Upgrade
EBITDA Margin	-653.93%	-	-	-311.23%	-23.10%	-	Upgrade
Depreciation & Amortization	-0.11	0	0.01	0.34	0.22	0.11	Upgrade
EBIT	-10.53	-11.9	-18.6	-17.93	-1.5	-10.13	Upgrade
EBIT Margin	-647.06%	-	-	-317.21%	-27.00%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).